A mutually-successful partnership is important to the Global Licensing & New Business Development (GLNBD) organizations at Abbott Laboratories, and we are committed to giving your opportunity priority attention. Once submitted to Abbott Laboratories, the lead is carefully managed by our licensing professionals throughout the evaluation process, with status being communicated to you at each stage of our.

OUR EVALUATION PROCESS

Our review process includes several steps to ensure that the opportunity falls within Abbott's area of scientific focus and strategic direction, with the goal of establishing a mutually-beneficial partnership with your company.

In the screening phase of our evaluation, the details of the opportunity are reviewed to determine if your proposal complements our principal businesses.

The opportunity is then sent to key internal experts for assessment of the scientific and, as appropriate, commercial potential before contacting you with next steps.

If a strategic fit is recognized and is championed by the scientific and commercial organizations, the opportunity is fully explored via due diligence to determine if a mutually-agreeable partnership can be formed.

Discussions and negotiations then take place to determine appropriate terms for the proposed venture and, after contract negotiations and finalization, deal closure and integration planning occurs.

Ultimately, a mutual vision of the partnership is reached and commences according to the executed licensing agreement.

WHY ABBOTT LABORATORIES?

At Abbott Laboratories, we recognize that there are many organizations with which you can choose to partner. Our difference is that we focus on the true value of a partnership, both in terms of business impact as well as the benefits our products can provide to quality health care worldwide.

It is our mission to work with you to establish a mutually-beneficial alliance.

Let us demonstrate how we achieve success at Abbott Laboratories.